Inscrivez-vous gratuitement à la newsletter :
Utilisez la recherche :
Stratégie Sectorielle : Soins de santé
Dividendes et valorisation des principales sociétés cotées américaines des soins de santé.
- Vous n’êtes pas identifié.
-
Stratégie Sectorielle
Soins de santé
Méga capitalisations boursières4 (Cap. ≥ 200 Md€)
| Société | Cap.1 | Rdt. % | PER2 | Bêta | Cours | +bas3 | +haut3 | Industrie | |
|---|---|---|---|---|---|---|---|---|---|
 | Johnson & Johnson | 316,9 | 2,7% | 14,7 | 0,8 | 134,3 | -10% | 11% | Drug Manufacturers - Major |
| UnitedHealth Group | 224,6 | 1,7% | 16,0 | 0,7 | 265,9 | -22% | 8% | Health Care Plans |
| Pfizer | 209,5 | 3,4% | 13,8 | 0,4 | 42,4 | -12% | 10% | Drug Manufacturers - Major |
Grosses capitalisations boursières4 (200 Md€ > Cap. ≥ 10 Md€)
| Société | Cap.1 | Rdt. % | PER2 | Bêta | Cours | +bas3 | +haut3 | Industrie | |
|---|---|---|---|---|---|---|---|---|---|
| Merck | 182,4 | 2,7% | 15,0 | 0,3 | 79,7 | -22% | 9% | Drug Manufacturers - Major |
| Abbott Laboratories | 131,6 | 1,5% | 23,3 | 0,9 | 83,9 | -27% | 2% | Medical Devices |
| Medtronic | 118,3 | 2,2% | 16,7 | 0,5 | 99,3 | -18% | 1% | Medical Devices |
| Thermo Fisher Scientific | 103,4 | 0,3% | 21,5 | 1,2 | 290,9 | -29% | 5% | Diagnostics & Research |
| Amgen | 94,8 | 3,3% | 11,9 | 1,0 | 174,9 | -5% | 20% | Drug Manufacturers - Major |
| Eli Lilly | 93,4 | 2,4% | 16,5 | 0,3 | 108,3 | -19% | 22% | Drug Manufacturers - Major |
| AbbVie | 92,3 | 6,0% | 7,5 | 0,8 | 70,3 | -7% | 43% | Drug Manufacturers - Major |
| Danaher | 89,1 | 0,5% | 24,5 | 0,8 | 140,0 | -32% | 4% | Diagnostics & Research |
| Gilead Sciences | 74,9 | 3,8% | 9,5 | 1,1 | 66,3 | -9% | 20% | Drug Manufacturers - Major |
| Anthem | 71,0 | 1,1% | 13,5 | 0,8 | 310,5 | -27% | 2% | Health Care Plans |
| Stryker | 68,6 | 1,0% | 23,1 | 1,0 | 206,4 | -30% | 2% | Medical Devices |
| CVS Health | 66,4 | 3,6% | 8,1 | 1,1 | 57,6 | -10% | 43% | Health Care Plans |
| Bristol-Myers Squibb | 64,4 | 3,7% | 9,9 | 0,7 | 44,3 | -1% | 44% | Drug Manufacturers - Major |
| Becton Dickinson | 60,6 | 1,2% | 19,4 | 1,2 | 252,9 | -18% | 5% | Medical Instruments & Supplies |
| Cigna | 60,4 | - | 9,7 | 1,0 | 179,2 | -21% | 26% | Health Care Plans |
| Celgene | 57,6 | - | 7,4 | 1,6 | 91,9 | -36% | 8% | Drug Manufacturers - Major |
| Intuitive Surgical | 54,0 | - | 38,9 | 1,3 | 526,3 | -18% | 12% | Medical Instruments & Supplies |
| Boston Scientific | 52,2 | - | 23,6 | 0,7 | 42,3 | -25% | 3% | Medical Devices |
| Allergan | 48,3 | 1,8% | 9,7 | 2,0 | 165,9 | -31% | 19% | Drug Manufacturers - Specialty & Generic |
| Zoetis | 48,2 | 0,6% | 29,3 | 0,7 | 113,3 | -30% | 3% | Drug Manufacturers - Specialty & Generic |
| HCA Healthcare | 43,0 | 1,2% | 12,4 | 1,3 | 141,5 | -25% | 4% | Medical Care |
| Vertex Pharmaceuticals | 40,0 | - | 29,2 | 1,2 | 175,8 | -14% | 11% | Biotechnology |
| Biogen | 39,9 | - | 7,5 | 1,5 | 231,4 | -7% | 68% | Drug Manufacturers - Major |
| Illumina | 39,9 | - | 39,8 | 1,3 | 305,1 | -12% | 25% | Diagnostics & Research |
| Baxter International | 37,0 | 1,1% | 21,9 | 1,1 | 81,7 | -25% | 1% | Medical Instruments & Supplies |
| Edwards Lifesciences | 35,4 | - | 32,7 | 1,0 | 191,5 | -30% | 3% | Medical Devices |
| Humana | 35,0 | 0,8% | 15,5 | 1,0 | 291,3 | -23% | 22% | Health Care Plans |
| Regeneron Pharmaceuticals | 28,5 | - | 12,1 | 1,0 | 292,6 | -2% | 51% | Biotechnology |
| IQVIA Holdings | 27,6 | - | 21,7 | 1,2 | 157,4 | -33% | 4% | Diagnostics & Research |
| Alexion Pharmaceuticals | 24,1 | - | 11,2 | 1,8 | 120,8 | -23% | 17% | Biotechnology |
| McKesson | 24,0 | 1,1% | 943,2 | 1,3 | 144,6 | -27% | 3% | Medical Distribution |
| Zimmer Biomet Holdings | 21,9 | 0,8% | 14,6 | 1,4 | 120,6 | -20% | 12% | Medical Devices |
| IDEXX Laboratories | 21,7 | - | 51,4 | 1,2 | 284,2 | -38% | 1% | Diagnostics & Research |
| Align Technology | 20,2 | - | 39,7 | 2,4 | 283,9 | -37% | 40% | Medical Devices |
| Agilent Technologies | 20,1 | 0,9% | 21,1 | 1,3 | 71,7 | -15% | 15% | Diagnostics & Research |
| Centene | 20,0 | - | 11,1 | 0,8 | 54,5 | -17% | 37% | Health Care Plans |
| Mettler-Toledo International | 18,4 | - | 32,8 | 1,4 | 835,4 | -40% | 5% | Diagnostics & Research |
| AmerisourceBergen | 16,8 | 1,8% | 12,2 | 1,2 | 89,9 | -23% | 6% | Medical Distribution |
| ResMed | 15,9 | 1,2% | 32,6 | 0,3 | 124,4 | -27% | 0% | Medical Instruments & Supplies |
| Laboratory of America Holdings | 15,4 | - | 14,5 | 1,0 | 175,5 | -32% | 8% | Diagnostics & Research |
| Incyte | 15,3 | - | 27,5 | 1,0 | 80,1 | -29% | 11% | Biotechnology |
| The Cooper | 14,6 | - | 25,0 | 0,9 | 330,9 | -31% | 4% | Medical Instruments & Supplies |
| Teleflex | 13,7 | 0,4% | 26,2 | 1,1 | 334,3 | -32% | 1% | Medical Instruments & Supplies |
| Waters | 13,4 | - | 21,4 | 1,1 | 217,1 | -23% | 18% | Diagnostics & Research |
| BioMarin Pharmaceutical | 13,2 | - | 276,5 | 1,2 | 83,0 | -5% | 29% | Biotechnology |
| Exact Sciences | 13,2 | - | -100,8 | 2,4 | 114,9 | -58% | 6% | Diagnostics & Research |
| WellCare Health Plans | 13,1 | - | 17,7 | 1,0 | 292,4 | -25% | 11% | Health Care Plans |
| Cardinal Health | 12,6 | 4,0% | 917,0 | 1,7 | 47,6 | -12% | 23% | Medical Distribution |
| Quest Diagnostics | 12,3 | 2,1% | 15,1 | 0,9 | 103,0 | -23% | 12% | Diagnostics & Research |
| DexCom | 12,1 | - | 124,3 | 1,0 | 149,2 | -38% | 6% | Diagnostics & Research |
| DENTSPLY SIRONA | 11,8 | 0,6% | 21,4 | 0,7 | 56,9 | -40% | 4% | Medical Instruments & Supplies |
| Hologic | 11,3 | - | 18,0 | 1,0 | 47,3 | -21% | 5% | Medical Instruments & Supplies |
| Varian Medical Systems | 10,9 | - | 25,2 | 0,9 | 134,9 | -25% | 6% | Medical Instruments & Supplies |
| Universal Health Services | 10,6 | 0,3% | 12,3 | 1,2 | 132,9 | -16% | 7% | Medical Care |
| Abiomed | 10,6 | - | 45,1 | 1,0 | 262,7 | -13% | 75% | Medical Devices |
 | Canopy Growth | 10,5 | - | -148,6 | 5,2 | 44,6 | -29% | 72% | Drug Manufacturers - Specialty & Generic |
Moyennes capitalisations boursières4 (10 Md€ > Cap. ≥ 2 Md€
| Société | Cap.1 | Rdt. % | PER2 | Bêta | Cours | +bas3 | +haut3 | Industrie | |
|---|---|---|---|---|---|---|---|---|---|
| PerkinElmer | 9,4 | 0,3% | 20,6 | 1,5 | 95,2 | -25% | 8% | Diagnostics & Research |
| Henry Schein | 9,4 | - | 18,8 | 0,8 | 70,6 | -20% | 3% | Medical Distribution |
| Seattle Genetics | 9,1 | - | -155,6 | 1,8 | 63,8 | -20% | 32% | Biotechnology |
| Mylan | 8,8 | - | 4,2 | 2,1 | 19,2 | -13% | 106% | Drug Manufacturers - Specialty & Generic |
| DaVita | 8,4 | - | 10,9 | 2,1 | 56,9 | -24% | 39% | Medical Care |
| West Pharmaceutical Services | 8,1 | 0,5% | 37,4 | 1,4 | 124,4 | -26% | 2% | Medical Instruments & Supplies |
| Bausch Health | 7,4 | - | 8,2 | 1,8 | 30,8 | -23% | 19% | Drug Manufacturers - Specialty & Generic |
| Alnylam Pharmaceuticals | 6,8 | - | -9,8 | 2,4 | 71,5 | -16% | 74% | Biotechnology |
| Jazz Pharmaceuticals | 6,7 | - | 7,7 | 1,0 | 133,1 | -15% | 36% | Biotechnology |
| Perrigo | 6,3 | 1,7% | 12,1 | 1,9 | 51,8 | -30% | 56% | Drug Manufacturers - Specialty & Generic |
| Nektar Therapeutics | 5,2 | - | -12,5 | 3,0 | 33,7 | -13% | 107% | Biotechnology |
| Alkermes | 3,1 | - | 2 253,0 | 1,5 | 22,5 | -6% | 109% | Biotechnology |
Petites capitalisations boursières4 (2 Md€ > Cap. ≥ 300 M€)
| Société | Cap.1 | Rdt. % | PER2 | Bêta | Cours | +bas3 | +haut3 | Industrie | |
|---|---|---|---|---|---|---|---|---|---|
| ProQR Therapeutics | 0,3 | - | -4,7 | -0,1 | 9,1 | -29% | 165% | Biotechnology |
1 Ou contre-valeur en € d’après la parité en vigueur 2 Prévision si disponible 3 Ecart par rapport au +bas/haut à 52 semaines
4 Les données peuvent comporter des inexactitudes : ne prenez pas de décisions d’investissement sur leur seule base.
Déposez vos remarques et suggestions sur les forums : Screeners de l’IH.